Join our expert panel as they discuss the future of type 2 diabetes, what is the evolving role of continuous glucose monitoring (CGM) in type 2 and what treatment options will support patients and their health care professionals to improve patient outcomes.

With / speaker(s); 

Dr. Jackie Elliot is a Clinical Lead for Diabetes, Senior Clinical Lecturer, and Honorary Consultant at Sheffield Teaching Hospitals NHS Foundation Trust. 

Dr Sarah Davies  GP Partner at Woodlands Medical Centre in Cardiff, Clinical Director for Diabetes for the Primary, Community and Intermediate Care board at Cardiff and Vale UHB, All Wales Primary Care lead for Diabetes.

Prof Sam Seidu Professor in Primary Care Diabetes and Cardio-metabolic Medicine, University of Leicester/ GP
Waqas Tahir,  GP Partner/Diabetes Clinical Lead at Affinity Care/West Yorkshire ICB. 

*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Jackie Elliot Study
Elliott J. et al Clinical outcomes of a real-world prospective study using Dexcom ONE continuous glucose monitoring in people with diabetes treated with two or more insulin injections per day. Diabet Med. 2025.e15519.

NICE. Type 2 diabetes in adults: management.  Accessed March, 2025.
https://www.nice.org.uk/guidance/ng28

† © NICE [2023]. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

MAT-7897

Hear what we have coming up in Season 3 of the Diabetes Dialogues podcast.

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Adam Dawes speaks to Professor Sam Seidu about the financial impact of managing Type 2 diabetes within the NHS system. Looking at direct and indirect costs, the importance of early intervention, and the challenges of sustaining high-cost treatments like GLP-1 receptor agonists and continuous glucose monitoring (CGM).  A great introduction to heath economics around diabetes within the UK health system. 

With speaker; Prof.Sam Seidu Professor in Primary Care Diabetes and Cardio-metabolic Medicine, University of Leicester/ GP 

*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.


NICE. Type 2 diabetes in adults: management.  Accessed March, 2025.
https://www.nice.org.uk/guidance/ng28

† © NICE [2023]. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

MAT-7903

Hear what we have coming up in Season 3 of the Diabetes Dialogues podcast.

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

This podcast discusses how diabetes specialists and general practitioners can collaborate to manage patients with type 2 diabetes effectively. Dr. Jackie Elliot and Dr. Sarah Davies share their insights on the importance of specialist care for complex cases and the role of general practice in managing the majority of patients.  A really great insight from two very experienced healthcare professionals that to help you navigate the changing role of general practice in diabetes management.

With / speaker; 

Dr. Jackie Elliot is a Clinical Lead for Diabetes, Senior Clinical Lecturer, and Honorary Consultant at Sheffield Teaching Hospitals NHS Foundation Trust. 
Dr Sarah Davies  GP Partner at Woodlands Medical Centre in Cardiff, Clinical Director for Diabetes for the Primary, Community and Intermediate Care board at Cardiff and Vale UHB, All Wales Primary Care lead for Diabetes.

*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Jackie Elliot Study
Elliott J. et al Clinical outcomes of a real-world prospective study using Dexcom ONE continuous glucose monitoring in people with diabetes treated with two or more insulin injections per day. Diabet Med. 2025.e15519.

NICE. Type 2 diabetes in adults: management. Accessed March, 2025.
https://www.nice.org.uk/guidance/ng28

† © NICE [2023]. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

MAT-7898

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Our very own specialist dietician Nicola Rainford meets with a fellow dietitian Nasurat Kausar to discuss the evolving role of primary care dietitians in managing type 2 diabetes. Exploring the expanding role of continuous glucose monitoring (CGM) and tailored dietary advice for holistic patient care. Find out more about the role dieticians have to play from diagnosis through various stages of diabetes management to support their patients.  

With / speaker; 

Nusrat Kausar RD from Primary Care Dietitians

Refs for description

*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

NICE. Type 2 diabetes in adults: management NG28.  Accessed March, 2025.

https://www.nice.org.uk/guidance/ng28

† © NICE [2023]. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

NDPP refers to; National Diabetes Prevention Program. Accessed May, 2025. https://www.england.nhs.uk/diabetes/diabetes-prevention/

https://www.primarycaredietitians.co.uk/

MAT-7902

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Dr. Sarah Davies, a GP from Cardiff with 14 years experience, discusses the crucial role of general practice in managing type 2 diabetes, emphasizing the importance of early diagnosis, patient empowerment, and continuity of care. Learn about the challenges faced by GPs in providing comprehensive care due to increasing demand and changing models of care.

With / speaker; 

Dr Sarah Davies  GP Partner at Woodlands Medical Centre in Cardiff, Clinical Director for Diabetes for the Primary, Community and Intermediate Care board at Cardiff and Vale UHB, All Wales Primary Care lead for Diabetes.

*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

MAT-7900

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Adam and Prof. Sam Seidu take a deeper look into various real world studies and clinical trials that have been conducted in a T2 diabetes cohort using continuous glucose monitoring technology.  Discussing the key findings, that can enhance understanding and care for T2 patients.  

With / speaker; 

Prof. Sam Seidu Professor in Primary Care Diabetes and Cardio-metabolic Medicine, University of Leicester/ GP

*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. 

IMMEDIATE study

Aronson R et al. IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trial. Diabetes Obes Metab. 2023;25(4):1024-1031.

MOBILE study

Aleppo G et al.  The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care. 2021;44(12):2729-2737. 

 MAT-7904

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Explore the evolving role of continuous glucose monitoring (CGM) in managing type 2 diabetes, with a focus on NICE NG28 guidance1. Host Adam Dawes and his guest Dr. Jackie Elliott discuss the criteria for CGM use, the transition from intermittently-scanned CGM to real-time CGM, and the comparison of NICE guidelines with international standards

With / speaker; 

Dr. Jackie Elliot is a Clinical Lead for Diabetes, Senior Clinical Lecturer, and Honorary Consultant at Sheffield Teaching Hospitals NHS Foundation Trust. 

*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Jackie Elliot Study

Elliott J. et al. Clinical outcomes of a real-world prospective study using Dexcom ONE continuous glucose monitoring in people with diabetes treated with two or more insulin injections per day. Diabet Med. 2025.e15519.

NICE. Type 2 diabetes in adults: management.  Accessed March, 2025.

https://www.nice.org.uk/guidance/ng28

† © NICE [2023]. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

Other guidance mentioned.

ADA. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes.  Diabetes Care. 2025;48:S14–S26

SIGN. Optimising glycaemic control in people with type 1 diabetes. Accessed March 2025. http:// www.sign.ac.uk/ our-guidelines/optimising-glycaemic-control-in-people-with-type-1-diabetes/

Davies MJ, et al. Consensus report on management of hyperglyceamia in T2D. Diabetologia. 2022;65: 1925–1966

MAT-7899

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Dr. Waqas Tahir, a GP from Bradford, discusses various strategies for managing type 2 diabetes, including lifestyle interventions, pharmaceutical treatments, and the use of technology1. He emphasizes the importance of personalised care and the evolving role of new medications and continuous glucose monitoring in improving patient outcomes.

With / speaker; 

Dr Waqas Tahir GP Partner at Affinity Care Partnership, Bradford, and serves as the Diabetes Clinical Lead for the West Yorkshire Integrated Care Board

*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

MAT-7901

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Cathy Campbell is the first diabetes technology specialist midwife in the UK working at the Leicester Diabetes Centre in a role only recently introduced post the NICE TA943 on Hybrid Closed Loop.  

Cathy shares her expertise and insight on supporting people who are pregnant with type 1 or type 2 diabetes with Nic Taylor professional education specialist here at Dexcom UK & Ireland.  

Learn more about why it is important to keep glucose levels within the advised ranges during pregnancy and how technology has a role to play in this. A great listen not only for those working in diabetes but anyone working in pregnancy services in the UK and Ireland. 

If there is referral to pregnant women / ladies. This is not that we don’t acknowledge that some people we provide care for, don’t identify as women, but for the purpose of this podcast – the term women / ladies is used.

With / speaker; 

Cathy Campbell, Diabetes Specialist Midwife (Technology), Leicester Diabetes Centre

*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

NICE. Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. Accessed July 2024. https://www.nice.org.uk/guidance/ta943†

NICE. Diabetes in pregnancy: management from preconception to the postnatal period. Accessed July, 2024. https://www.nice.org.uk/guidance/ng3 †

NHS England. Saving babies’ lives: version 3. Accessed July, 2024. https://www.england.nhs.uk/long-read/saving-babies-lives-version-3

† © NICE [2023]. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

MAT-6487

Hear what we have coming up in Season 3 of the Diabetes Dialogues podcast.

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Nicola Taylor RD is our professional education specialist here at Dexcom UK and Ireland, Nic joined Dexcom in May 2023 from her role in the NHS managing the pump service at Derby. Nic will share her experience of HCL implementation in the NHS with host Adam Dawes. This podcast was recorded in July 2024. 

With / speaker; 

Nicola Taylor – Professional Education Specialist at Dexcom UK & Ireland & Adam Dawes – Host.

 MAT-6215

*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

NICE. Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. https://www.nice.org.uk/guidance/ta943

© NICE [2023]. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

Hear what we have coming up in Season 3 of the Diabetes Dialogues podcast.

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Nicola Taylor and Adam Dawes are not only our professional education specialists here at Dexcom but have a wealth of experience as diabetes clinicians in their previous roles in the NHS.  Bringing that experience and their knowledge of CGM Nic and Adam will give you the run down on Time in Range (TIR) and using this in clinical practice. Touching on shared decision making and setting achievable targets for patients to achieve the best patient care.

With / speaker; 
Adam Dawes professional education specialist UK and Ireland previously 10 years as paediatric diabetes nurse specialist in the NHS

Nicola Taylor professional education specialist UK and Ireland with 13 years in the NHS as a diabetes specialist dietician.

*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Dexcom Clarity

*An internet connection is required for patients to send their glucose data to Dexcom Clarity via a compatible smart device: dexcom.com/compatibility 
† Healthcare Professionals will only be able to view a patient’s glucose data if the patient selects to share it with them through Dexcom CLARITY.  
‡Register for Dexcom CLARITY at clarity.dexcom.com/professional/registration 

Hear what we have coming up in Season 3 of the Diabetes Dialogues podcast.

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Adam talks to two experts in diabetes care of children and young adults.  John Pemberton is a diabetes specialist dietician at Birmingham Children’s Hospital and Amy Jolley a highly specialised diabetes dietician in Salford.  They discuss paediatric diabetes care right through to the transition of young adults into the adult diabetes services.  What are the challenges at each stage and how to set out strategies and advice for patients and their parents and carers. 

With / speaker; 
John Pemberton RD specialist diabetes dietician Department of Endocrinology and Diabetes, Birmingham Children’s Hospital and Amy Jolley Amy Jolley RD MSc, Highly Specialist Diabetes Dietitian, Salford Care Organisation.
Refs for description

*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

What is MARD as a measure for CGM accuracy? What does it mean and how is it calculated?  John Pemberton discusses how to look at accuracy studies across different CGM devices and the differences between CE mark approvals in the UK and USA/Australia.  An enlightening listen around something you may see everyday as a healthcare professional but would like to know more about.  Link to the study discussed is in the show notes. 


With / speaker; 
John Pemberton RD specialist diabetes dietician Department of Endocrinology and Diabetes, Birmingham Children’s Hospital 

Refs for description
*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

John S Pemberton et al, CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review. Diabetes Obes Metab. 2023; 25(4):916-939.

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Good skin preparation is an essential component of applying a CGM sensor. Dr. Emma Wilmot talks to Adam about ideas and options to support any patients suffering with a skin irritation and to help prevent it occurring.


With / speaker; 
Dr Emma Wilmot MB ChB BSc (hons) PhD FRCP , Consultant Diabetologist, University Hospitals of Derby and Burton NHS Foundation Trust , Honorary (Clinical) Associate Professor, University of Nottingham, Founder, Diabetes Technology Network 

Refs for description
*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Stefania Guerra Director Scientific Affairs at Dexcom talks to Professor Helen R. Murphy about her landmark study; AiDAPT which looks at the use of hybrid closed loop in pregnancy amongst pregnant women with type 1 diabetes.  

Helen will give the background to this randomised controlled trial undertaken during the pandemic and the results showing how automated insulin delivery (AID) in pregnancy can support the tight time in range that is so important for people living with diabetes who are pregnant. They will also explore why this is so important across all stages of pregnancy and the future implications on the care of pregnant women of this study and its results. A great listen for anyone looking after people who are pregnant with type 1 diabetes. Refs for description.

With; Stefania Guerra Ph.D, Msc. Director Scientific Affairs, Dexcom & Professor Helen R. Murphy MBBChBAO, MD, FRACP

Clinical Papers mentioned;
Tara T M Lee, et al.  AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial - study protocol. BMC Pregnancy Childbirth. 2022 Apr 5;22(1):282.
Feig, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet, 2017 Nov 25;390(10110):2347-2359.


Lawton J, et al. Listening to women: experiences of using closed-loop in type 1 diabetes pregnancy. Diabetes Technol Ther, 2023 Dec;25(12):845-855.

MAT-5077

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Are you a healthcare professional new to Hybrid Closed Loop (HCL) systems or looking to find out more? This podcast with Prof.Pratik Choudray and Dr.Emma Wilmot from the Diabetes Technology Network (DTN) touches on the fundamental skills a patient needs to get the best benefit from a HCL system. Includes an interview with HCL therapy user Jamie Fowler to give a great insight in what living with a HCL system is like for a person living with diabetes.

With; 
Pratik Choudhary
Professor of Diabetes, Leicester Diabetes Centre, University of Leicester
Hon Consultant in Diabetes, University Hospitals Leicester
Chair - Diabetes Technology Network-UK
Clinical Lead for Type 1 Diabetes – Midlands

And

Dr Emma Wilmot MB ChB BSc (hons) PhD FRCP , Consultant Diabetologist, University Hospitals of Derby and Burton NHS Foundation Trust , Honorary (Clinical) Associate Professor, University of Nottingham, Founder, Diabetes Technology Network UK

Hosted by; Adam Dawes – our very own Professional Education Specialist here at Dexcom

MAT-1028

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Dr. Emma Wilmot associate professor at the University of Nottingham, and consultant diabetologist in Derby talks to Adam about best practice for setting the different CGM glucose alerts to best support people living with diabetes.  Including how to set actionable alerts to support people in day to day life to ensure smoother glucose levels avoiding hypoglyceamia and re-bound hyperglyceamia events. 


With; 
Dr Emma Wilmot MB ChB BSc (hons) PhD FRCP , Consultant Diabetologist, University Hospitals of Derby and Burton NHS Foundation Trust , Honorary (Clinical) Associate Professor, University of Nottingham, Founder, Diabetes Technology Network

Urgent low soon alert available with Dexcom G6 and G7 only.  Delay 1st High Alert available with Dexcom ONE+ and G7 only.  

MAT-4784

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

Adam talks to John Pemberton a diabetes specialist dietician who supports children and young people with diabetes at Birmingham Children’s Hospital.  He discussed how CGM arrows can inform treatment decisions around activity and exercise and support people with diabetes to use activity to manage glucose levels.

With; 
Dr John Pemberton RD
Department of Endocrinology and Diabetes, Birmingham Children’s Hospital

MAT-4783

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub

An insightful podcast that is a must for anyone looking after people with diabetes.  Dr.Rose Stewart is a clinical psychologist specialising caring for people living with diabetes. Find out how Dr.Stewart navigates the additional psychological and sociological challenges living with diabetes can create.

With; 
Dr. Rose Stewart
BSc (Hons), DCLINPSY, CPSYCHOL. Consultant Clinical Psychologist & Diabetes Psychology Service Lead, Betsi Cadwaladr University Health Board.

MAT-5075

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.

Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.

Further CPD accredited education can be found on the Dexcom Education Hub